Optimizing Outcomes in Patients with oHCM: The Emerging Role of Cardiac Myosin Inhibitors

EBAC-accredited Satellite Symposium during ESC Congress 2025, Madrid, Spain

Live Meeting

0.75 available credits

Information

31 august, 2025

10:00 - 10:45 CEST

IFEMA MADRID
Room: ALGIERS, Spain

Optimizing Outcomes in Patients with Obstructive Hypertrophic Cardiomyopathy Evidence Based Application of Novel Therapies

ENROLL

Details

Presenters

Overview
Invitation to the EBAC-accredited Satellite Symposium "Optimizing Outcomes in Patients with oHCM: The Emerging Role of Cardiac Myosin Inhibitors"
For more information, please visit the ESC website.
Learning objectives
The educational objectives of the symposium are to:
Analyze the current benefits and limitations of GDMT in managing patients with obstructive hypertrophic cardiomyopathy (oHCM)
Compare and contrast the pharmacologic properties, efficacy and safety profiles of cardiac myosin inhibitors in managing patients with symptomatic oHCM
Evaluate the efficacy and safety of cardiac myosin inhibitors in managing patients with oHCM
Agenda
10:00 – 10:05 Introduction - Caroline Coats, MD, PhD – Glasgow, UK
10:05 – 10:13 Diagnostic Challenges and Persistent Unmet Therapeutic Needs - Iacopo Olivotto, MD – Florence, Italy
10:13 – 10:28 The Evolution of HCM Therapeutic Landscape: Emerging Evidence About Cardiac Myosin Inhibitors - Ahmad Masri, MD – Portland, OR, USA
10:28 – 10:36 The Evolving Role of Cardiac Myosin Inhibitors in Obstructive HCM - Fabian Knebel, MD, PhD – Berlin, Germany
10:36 – 10:45 Panel Discussion and Q&A - All faculty
Accreditation
This programme is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) with 45 minutes effective education time. Each participant should claim only those hours of credit that have actually been spent in the educational activity. The Accreditation Council for Continuing Medical Education (ACCME®) and EBAC have recognized each other’s accreditation systems as substantially equivalent.
Funding
This symposium is supported by an unrestricted educational grant from Cytokinetics.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
  Apple Safari for Mac OS and iOS
  Mozilla Firefox for Windows, Mac OS, iOS, and Android
  Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+

Caroline Coats, MD

Iacopo Olivotto, MD

Ahmad Masri, MD, MS

Fabian Knebel, MD, PhD

Details

Presenters

Overview
Invitation to the EBAC-accredited Satellite Symposium "Optimizing Outcomes in Patients with oHCM: The Emerging Role of Cardiac Myosin Inhibitors"
For more information, please visit the ESC website.
Learning objectives
The educational objectives of the symposium are to:
Analyze the current benefits and limitations of GDMT in managing patients with obstructive hypertrophic cardiomyopathy (oHCM)
Compare and contrast the pharmacologic properties, efficacy and safety profiles of cardiac myosin inhibitors in managing patients with symptomatic oHCM
Evaluate the efficacy and safety of cardiac myosin inhibitors in managing patients with oHCM
Agenda
10:00 – 10:05 Introduction - Caroline Coats, MD, PhD – Glasgow, UK
10:05 – 10:13 Diagnostic Challenges and Persistent Unmet Therapeutic Needs - Iacopo Olivotto, MD – Florence, Italy
10:13 – 10:28 The Evolution of HCM Therapeutic Landscape: Emerging Evidence About Cardiac Myosin Inhibitors - Ahmad Masri, MD – Portland, OR, USA
10:28 – 10:36 The Evolving Role of Cardiac Myosin Inhibitors in Obstructive HCM - Fabian Knebel, MD, PhD – Berlin, Germany
10:36 – 10:45 Panel Discussion and Q&A - All faculty
Accreditation
This programme is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) with 45 minutes effective education time. Each participant should claim only those hours of credit that have actually been spent in the educational activity. The Accreditation Council for Continuing Medical Education (ACCME®) and EBAC have recognized each other’s accreditation systems as substantially equivalent.
Funding
This symposium is supported by an unrestricted educational grant from Cytokinetics.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
  Apple Safari for Mac OS and iOS
  Mozilla Firefox for Windows, Mac OS, iOS, and Android
  Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+

Caroline Coats, MD

Iacopo Olivotto, MD

Ahmad Masri, MD, MS

Fabian Knebel, MD, PhD

Recommended

Title

Share on ReachMD